Related Experiment Video
Updated: Mar 27, 2026

11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
441
Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy
Yi Liu1, Gang Chen1, Xiaoming Qiu1
1Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China.
Thoracic Cancer
|January 15, 2016
Summary
Intrapulmonary Castleman disease, a rare condition, was successfully treated with surgery in one patient. This case highlights the importance of considering Castleman disease in lung cancer diagnoses.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Castleman disease (angiofollicular lymph node hyperplasia) presents as unicentric or multicentric forms.
- Intrapulmonary Castleman disease is an exceptionally rare manifestation.
Purpose of the Study:
- To report a rare case of intrapulmonary Castleman disease.
- To emphasize its differential diagnosis with primary lung malignancies.
Main Methods:
- A patient underwent left upper pulmonary lobectomy for a suspected lung tumor.
- Histopathologic examination confirmed hyaline-type Castleman disease.
Main Results:
- The patient recovered well post-surgery.
- No recurrence or distant metastasis was observed during a two-year follow-up.
Conclusions:
- Unicentric Castleman disease in the lung, though rare, is a crucial consideration in the differential diagnosis of primary pulmonary tumors.
- Surgical resection can be an effective treatment for intrapulmonary Castleman disease.
Related Concept Videos
Pulmonary Tuberculosis II
2.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis III
1.4K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.4K
Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Atypical Pneumonia
37
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Pulmonary Embolism I: Introduction
1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K

